<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="781px" height="3271px" viewBox="-0.5 -0.5 781 3271" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-25T23:45:24.907Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;5_Nvg57yAiXd9q3tUX79&quot; version=&quot;13.3.4&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?src=about#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1760" width="760" height="480" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2360" width="758" height="910" fill="none" stroke="#000000" pointer-events="all"/><rect x="428" y="2380" width="350" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 343px; height: 1px; padding-top: 2387px; margin-left: 435px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="435" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="98" y="2380" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2387px; margin-left: 105px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="105" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="20" y="1190" width="760" height="510" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="950" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Introduction</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Introduction</text></switch></g><rect x="90" y="140" width="690" height="230" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li>BAAR aérobie à croissance lente et à multiplication intra- et extra-cellulaire</li><li>localisation principalement <b>pulmonaire </b>(mais peut concerner n'importe quel organe)</li><li>chez l'imD : 50% localisations extra-pulmonaires, 25% disséminé, symptômes plus légers</li><li>France </li><ul><li>faible incidence : 7/100 000/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li><li>ALD pour 2 ans</li></ul><li>monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul><li><span style="font-size: 12px">Le traitement cible 3 <b>populations de BK</b> :</span></li><ul><li><span style="font-size: 12px">extra-cellulaires (95%) : contagiosité et symptômes ; ssb INH, RMP et streptomycine</span></li><li><span style="font-size: 12px">intra-cellulaires quiescents ; ssb PZA et RMP</span></li><li><span style="font-size: 12px">extra-cellulaires dans le caséeum : rechute ; ssb RMP</span></li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="410" width="690" height="220" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 402px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> pour limiter la multiplication de BK. L'afflux des monocytes épithélioïdes forme les granulomes giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des tuberculeux font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>développement d'une TM favorisé par :</li><ul><li>imD, diabète, InRé</li><li>fragilité : imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol><div><span style="color: rgba(0 , 0 , 0 , 0) ; font-family: monospace ; font-size: 0px">%3CmxGraphModel%3E%3Croot%3E%3CmxCell%20id%3D%220%22%2F%3E%3CmxCell%20id%3D%221%22%20parent%3D%220%22%2F%3E%3CmxCell%20id%3D%222%22%20value%3D%22%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B3%26amp%3Bnbsp%3Bpopulations%26amp%3Bnbsp%3Bde%20BK%20sont%20%C3%A0%20cibler%20%3A%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bextra-cellulaires%20(95%25)%20%3A%20contagiosit%C3%A9%20et%20sympt%C3%B4mes%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20INH%2C%20RMP%20et%20streptomycine%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bintra-cellulaires%20quiescents%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20PZA%20et%20RMP%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B%26lt%3Bspan%26gt%3Bextra-cellulaires%20dans%20le%20cas%C3%A9eum%20%3A%20rechute%26lt%3B%2Fspan%26gt%3B%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Bfont-family%3A%20%26amp%3B%2334%3Bkarla%26amp%3B%2334%3B%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20RMP%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3B%2Ful%26gt%3B%22%20style%3D%22text%3Bhtml%3D1%3B%22%20vertex%3D%221%22%20parent%3D%221%22%3E%3CmxGeometry%20x%3D%22120%22%20y%3D%22560%22%20width%3D%22430%22%20height%3D%22120%22%20as%3D%22geometry%22%2F%3E%3C%2FmxCell%3E%3C%2Froot%3E%3C%2FmxGraphModel%3E</span><br /></div></div></div></div></foreignObject><text x="72" y="414" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="410" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 425px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="429" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="90" y="1210" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1202px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou cavités des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li><li>dès la suspicion, isoler le patient jusqu'à 15 jours de ttt</li></ul></div></div></div></foreignObject><text x="77" y="1214" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavités des lobes supérieurs et...</text></switch></g><rect x="20" y="1210" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1220px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="55" y="1224" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="20" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="55" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="88" y="1300" width="690" height="240" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font>3 prélèvements en 24h :<br /><ul><li><font>ECBC en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, tubage gastrique le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul></font></div></div></div></foreignObject><text x="95" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="20" y="1540" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1550px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="55" y="1554" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="90" y="1540" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1532px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulomes épithélioïdes gigantocellulaires avec nécrose caséeuse (très évocateur mais non pathognomonique de la tuberculose)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (résistance rifampicine ou INH)</li></ul></div></div></div></foreignObject><text x="77" y="1544" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 103 bacilles/mL. Répéter les...</text></switch></g><rect x="0" y="1170" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1185px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="40" y="1189" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="640" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 655px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">formes<br />pulmonaires</div></div></div></foreignObject><text x="60" y="659" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">formes...</text></switch></g><rect x="100" y="640" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 647px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme disséminée, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="659" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="990" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1005px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">vaccin</div></div></div></foreignObject><text x="60" y="1009" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">vaccin</text></switch></g><rect x="100" y="990" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 982px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risque</li><li>administration le plus tôt possible</li><li>pas de test tuberculinique préalable si nourrisson &lt; 3 mois, mais nécessaire jusqu'à 15 ans</li><li>CI si suspicion VIH ou imD (risque <b>BCGite disséminée</b> potentiellement létale)</li></ul></div></div></div></foreignObject><text x="87" y="994" fill="#000000" font-family="Karla" font-size="12px">le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risqueadministration le plus tô...</text></switch></g><rect x="20" y="2380" width="78" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 76px; height: 1px; padding-top: 2395px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="59" y="2399" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="2848" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 2863px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="2867" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="88" y="2848" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2855px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="95" y="2867" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2530" width="88" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 86px; height: 1px; padding-top: 2540px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="64" y="2544" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2340" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2355px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2359" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 218 2878 L 215.5 2878 Q 213 2878 213 2888 L 213 2895.5 Q 213 2903 210.5 2903 L 209.25 2903 Q 208 2903 210.5 2903 L 211.75 2903 Q 213 2903 213 2913 L 213 2920.5 Q 213 2928 215.5 2928 L 218 2928" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 268 2878 L 265.5 2878 Q 263 2878 263 2888 L 263 2895.5 Q 263 2903 260.5 2903 L 259.25 2903 Q 258 2903 260.5 2903 L 261.75 2903 Q 263 2903 263 2913 L 263 2920.5 Q 263 2928 265.5 2928 L 268 2928" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,263,2903)" pointer-events="all"/><rect x="218" y="2878" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2903px; margin-left: 219px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="238" y="2907" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="361" y="2878" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2893px; margin-left: 362px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="381" y="2897" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 411 2878 L 408.5 2878 Q 406 2878 406 2885.5 L 406 2889.25 Q 406 2893 403.5 2893 L 402.25 2893 Q 401 2893 403.5 2893 L 404.75 2893 Q 406 2893 406 2900.5 L 406 2904.25 Q 406 2908 408.5 2908 L 411 2908" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,406,2893)" pointer-events="all"/><path d="M 361 2878 L 358.5 2878 Q 356 2878 356 2885.5 L 356 2889.25 Q 356 2893 353.5 2893 L 352.25 2893 Q 351 2893 353.5 2893 L 354.75 2893 Q 356 2893 356 2900.5 L 356 2904.25 Q 356 2908 358.5 2908 L 361 2908" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="88" y="2958" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2965px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="95" y="2977" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="158" y="2988" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3008px; margin-left: 159px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="178" y="3012" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 158 2988 L 155.5 2988 Q 153 2988 153 2998 L 153 3003 Q 153 3008 150.5 3008 L 149.25 3008 Q 148 3008 150.5 3008 L 151.75 3008 Q 153 3008 153 3018 L 153 3023 Q 153 3028 155.5 3028 L 158 3028" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 208 2988 L 205.5 2988 Q 203 2988 203 2998 L 203 3003 Q 203 3008 200.5 3008 L 199.25 3008 Q 198 3008 200.5 3008 L 201.75 3008 Q 203 3008 203 3018 L 203 3023 Q 203 3028 205.5 3028 L 208 3028" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,203,3008)" pointer-events="all"/><rect x="288" y="2988" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3003px; margin-left: 289px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="308" y="3007" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 288 2988 L 285.5 2988 Q 283 2988 283 2995.5 L 283 2999.25 Q 283 3003 280.5 3003 L 279.25 3003 Q 278 3003 280.5 3003 L 281.75 3003 Q 283 3003 283 3010.5 L 283 3014.25 Q 283 3018 285.5 3018 L 288 3018" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 338 2988 L 335.5 2988 Q 333 2988 333 2995.5 L 333 2999.25 Q 333 3003 330.5 3003 L 329.25 3003 Q 328 3003 330.5 3003 L 331.75 3003 Q 333 3003 333 3010.5 L 333 3014.25 Q 333 3018 335.5 3018 L 338 3018" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,333,3003)" pointer-events="all"/><path d="M 648 2968 L 648 2967.79 L 658 2967.57 L 668 2967.3 L 678 2968.64 L 688 2967.31 L 698 2967.59 L 708 2968.49 L 718 2967.73 L 728 2968.36 L 738 2968.11 L 748 2967.26 L 758 2968 L 757.9 2968 L 758.04 2976 L 758.16 2984 L 758.04 2992 L 758.16 3000 L 758 3008 L 758 3008.41 L 748 3007.81 L 738 3007.44 L 728 3008.46 L 718 3008.07 L 708 3008.48 L 698 3008.3 L 688 3008.02 L 678 3008.57 L 668 3007.89 L 658 3008.73 L 648 3008 L 647.8 3008 L 647.79 3000 L 648.16 2992 L 648.03 2984 L 648 2976 L 648 2968 L 648 2968 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2988px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="703" y="2992" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="108" y="2530" width="670" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 663px; height: 1px; padding-top: 2537px; margin-left: 115px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, nausées, polynévrite sst-mot si carence B6, rarement tb neuro-psy, réactions cutanées ou algodystrophies (sd épaule-main)</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><span>EI : </span><b>coloration en orange</b><span> des larmes, sperme et urines (normal), nausées, phénomènes immuno-allergiques (thrombopénie, hémolyse, InRéA)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (changer), inhibiteurs de protéase, CTC, digitaliques, peut augmenter l'hépatotoxicité de INH et PZA</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé, déconseillée si grossesse</span></li><li><span style="font-size: 12px">EI : cytolise hépatique (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur, nausées</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : névrite optique rétrobulbaire (fris : posologie élevée, éthylisme chronique, InRé) nécessitant une cs ophtalmo tous les mois pendant le traitement</span></li></ul></ul><div>En <b>2e intention</b>, on peut utiliser des <b>aminosides </b>(streptomycine et amikacine). Les EI principaux sont les toxicités rénale et auditive. Les <b>FQ </b>sont aussi utilisables en 2e intention</div></div></div></div></foreignObject><text x="115" y="2549" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 428 2500 L 428 2380" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 648 2848 L 648 2847.34 L 658 2848.19 L 668 2848.43 L 678 2847.82 L 688 2848.2 L 698 2847.39 L 708 2847.93 L 718 2848.19 L 728 2848.27 L 738 2847.81 L 748 2847.49 L 758 2848 L 757.26 2848 L 757.62 2858 L 757.48 2868 L 758.06 2878 L 758.71 2888 L 758 2898 L 758 2897.74 L 748 2898.55 L 738 2898.09 L 728 2898.25 L 718 2898.07 L 708 2897.31 L 698 2897.38 L 688 2898.49 L 678 2898.06 L 668 2898.64 L 658 2898.45 L 648 2898 L 647.52 2898 L 648.13 2888 L 648.58 2878 L 648.42 2868 L 647.65 2858 L 648 2848 L 648 2848 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2873px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="703" y="2877" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 638 2908 L 638 2907.91 L 648 2908.48 L 658 2907.85 L 668 2908.36 L 678 2908.35 L 688 2908.55 L 698 2908.58 L 708 2907.72 L 718 2907.81 L 728 2908.6 L 738 2907.78 L 748 2908.12 L 758 2908 L 758.39 2908 L 758.61 2918 L 758.3 2928 L 758.56 2938 L 758.13 2948 L 758 2958 L 758 2957.99 L 748 2958.31 L 738 2957.31 L 728 2957.72 L 718 2958.72 L 708 2958.17 L 698 2958.23 L 688 2957.69 L 678 2958.17 L 668 2957.71 L 658 2958.09 L 648 2957.45 L 638 2958 L 637.26 2958 L 638.48 2948 L 638.73 2938 L 638.21 2928 L 637.89 2918 L 638 2908 L 638 2908 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 2933px; margin-left: 639px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="698" y="2937" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><rect x="90" y="1780" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1787px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les 2 moyens de dépister les ITL sont :</div><div><ul><li>IDR (= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul><li>interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li>lecture à 72h : IDR positive si induration &gt; 5 mm</li><li>suspicion ITL si <b>&gt; 10 mm sans BCG</b> ou augmentation<b> 10 mm entre 2 IDR en 3 mois</b></li></ul><li>IGRA (détection de production d'<span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul><li><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">meilleure VPP que l'IDR (osef BCG)</span></li><li><span style="font-size: 14px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1799" fill="black" font-family="Karla" font-size="12px">Les 2 moyens de dépister les ITL sont :...</text></switch></g><path d="M 598 1210 L 598 1210.38 L 608 1209.25 L 618 1210.68 L 628 1210.14 L 638 1209.54 L 648 1210.48 L 658 1210.1 L 668 1210.05 L 678 1210.36 L 688 1210.28 L 698 1209.93 L 708 1210.16 L 718 1210.28 L 728 1210.35 L 738 1209.65 L 748 1209.9 L 758 1210 L 758.1 1210 L 757.52 1220 L 757.33 1230 L 758.11 1240 L 758.01 1250 L 758.04 1260 L 758 1270 L 758 1269.92 L 748 1269.56 L 738 1269.5 L 728 1270.48 L 718 1269.68 L 708 1270.4 L 698 1270.34 L 688 1270.11 L 678 1269.31 L 668 1269.63 L 658 1270.55 L 648 1270.17 L 638 1269.59 L 628 1270.07 L 618 1269.52 L 608 1270.61 L 598 1270 L 597.37 1270 L 598.47 1260 L 597.69 1250 L 598.37 1240 L 598.63 1230 L 598.68 1220 L 598 1210 L 598 1210 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 158px; height: 1px; padding-top: 1240px; margin-left: 600px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"><span>Déclaration ARS :</span></div>- ITL d'enfant &lt; 15 ans<br />- TM confirmée ou suspectée</div></div></div></foreignObject><text x="600" y="1244" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration ARS :- ITL d'e...</text></switch></g><rect x="0" y="1740" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1755px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1759" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1780" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1790px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1794" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g><rect x="228" y="1950" width="60" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1960px; margin-left: 229px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">contact</div></div></div></foreignObject><text x="258" y="1964" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">contact</text></switch></g><path d="M 243 1970 L 210.64 1987.03" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 205.99 1989.48 L 210.55 1983.12 L 210.64 1987.03 L 213.81 1989.32 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 273 1970 L 294.88 1986.21" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 299.1 1989.33 L 291.39 1987.98 L 294.88 1986.21 L 295.56 1982.36 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 180.02 2020 L 180.15 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 180.16 2138.88 L 176.65 2131.89 L 180.15 2133.63 L 183.65 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="130" y="1990" width="100" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 2005px; margin-left: 132px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- enfant &lt; 2 ans<br />- imD sévère</div></div></div></foreignObject><text x="132" y="2009" fill="#000000" font-family="Karla" font-size="12px">- enfant &lt; 2 ans...</text></switch></g><rect x="130" y="2140" width="380" height="70" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe center; width: 378px; height: 1px; padding-top: 2147px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CHIMIOPROPHYLAXIE</div></div></div></foreignObject><text x="320" y="2159" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">CHIMIOPROPHYLAXIE</text></switch></g><rect x="280" y="1990" width="80" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 78px; height: 1px; padding-top: 2015px; margin-left: 282px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- répété<br />- rapproché<br />- fragile</div></div></div></foreignObject><text x="282" y="2019" fill="#000000" font-family="Karla" font-size="12px">- répété...</text></switch></g><rect x="370" y="1975" width="190" height="60" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 188px; height: 1px; padding-top: 2005px; margin-left: 372px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px">- avant ttt <span style="color: rgb(34 , 34 , 34) ; background-color: rgb(255 , 255 , 255) ; font-size: 12px">anti-TNFα<br /></span>- bilan VIH<br />- pro. santé<br />- migrants &lt; 15 ans forte endémie<br /></font></div></div></div></foreignObject><text x="372" y="2009" fill="#000000" font-family="Karla" font-size="12px">- avant ttt anti-TNFα...</text></switch></g><path d="M 320 2090 L 320 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2138.88 L 316.5 2131.88 L 320 2133.63 L 323.5 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="280" y="2060" width="80" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2075px; margin-left: 281px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IDR ou IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="320" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IDR ou IGRA&#xa;</text></switch></g><path d="M 320 2040 L 320 2053.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2058.88 L 316.5 2051.88 L 320 2053.63 L 323.5 2051.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 465 2035 L 465 2058.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465 2063.88 L 461.5 2056.88 L 465 2058.63 L 468.5 2056.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="340" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 341px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">bithérapie 3-4 mois<br /><div><span style="font-size: 14px ; font-weight: 400 ; background-color: rgb(255 , 255 , 255)">(INH + RMP)</span></div></div></div></div></foreignObject><text x="425" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">bithérapie 3-4 mois...</text></switch></g><rect x="300" y="2170" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2180px; margin-left: 301px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; "><span style="font-weight: normal">ou</span></div></div></div></foreignObject><text x="320" y="2184" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">ou</text></switch></g><rect x="130" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">monothérapie 6-9 mois<br /><span style="font-weight: normal">(INH)</span></div></div></div></foreignObject><text x="215" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">monothérapie 6-9 mois...</text></switch></g><rect x="125" y="2065" width="110" height="30" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2080px; margin-left: 126px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ne pas attendre la<br />confirmation d'ITL</div></div></div></foreignObject><text x="180" y="2084" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ne pas attendre la...</text></switch></g><path d="M 465.02 2085 L 465.14 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465.16 2138.88 L 461.64 2131.89 L 465.14 2133.63 L 468.64 2131.87 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="445" y="2065" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2075px; margin-left: 446px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="465" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IGRA&#xa;</text></switch></g><rect x="396" y="1950" width="100" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 1960px; margin-left: 398px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px"><b>autres situations</b><br /></font></div></div></div></foreignObject><text x="398" y="1964" fill="#000000" font-family="Karla" font-size="12px">autres situation...</text></switch></g><rect x="377" y="2100" width="210" height="20" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 208px; height: 1px; padding-top: 2110px; margin-left: 378px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div>ssi &lt; 18 ans, imD ou ITL récent (&lt; 1 an)<br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="482" y="2114" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ssi &lt; 18 ans, imD ou ITL récent (&lt;...</text></switch></g><rect x="20" y="1950" width="50" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 48px; height: 1px; padding-top: 1960px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CAT</div></div></div></foreignObject><text x="45" y="1964" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">CAT</text></switch></g><rect x="20" y="3060" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3075px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">cas particuliers</div></div></div></foreignObject><text x="55" y="3079" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">cas particu...</text></switch></g><rect x="90" y="3060" width="690" height="210" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 3052px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Roboto; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>grossesse</li><ul><li>supplémenter en B6 (INH), K1 (RMP)</li><li>en France, PZA déconseillée pendant grossesse et allaitement</li></ul><li>InRé</li><ul><li>clairance &gt; 30 : ttt normal</li><li>clairance = 15-30 : diminuer EMB, PZA</li><li>clairance &lt; 15 ou dialyse : diminuer INH, EMB, PZA</li></ul><li><span style="font-size: 12px">InHep</span></li><ul><li><span style="font-size: 12px">transaminases = 3-6N asymptomatique : arrêt PZA (peut être repris si retour à la normale)</span></li><li><span style="font-size: 12px">transaminases &gt; 6N ou symptomatique : arrêt INH et PZA voire du ttt antituberculeux</span></li></ul><li><span style="font-size: 12px">tuberculoses multi-résistantes</span></li><ul><li><span style="font-size: 12px">MDR (VS INH et RMP) : représente 2% des tuberculoses en France, ttt de 2e intention (aminosides, FQ)</span></li><li><span style="font-size: 12px">XDR (MDR + FQ + ...) : très mortelle mais exceptionnelle en France</span></li></ul></ul></div></div></div></foreignObject><text x="77" y="3064" fill="#000000" font-family="Roboto" font-size="12px">grossesse...</text></switch></g><path d="M 603 1310 L 603 1310.42 L 613 1309.53 L 623 1309.84 L 633 1310.05 L 643 1310.57 L 653 1310.36 L 663 1310.66 L 673 1309.42 L 683 1309.88 L 693 1309.58 L 703 1310.54 L 713 1310.37 L 723 1310.12 L 733 1309.51 L 743 1309.29 L 753 1310 L 752.37 1310 L 752.36 1320 L 752.46 1330 L 752.29 1340 L 753.14 1350 L 753 1360 L 753 1360.26 L 743 1360.63 L 733 1360.31 L 723 1359.35 L 713 1359.73 L 703 1360.44 L 693 1359.39 L 683 1360.63 L 673 1359.74 L 663 1360.08 L 653 1360.35 L 643 1360.2 L 633 1360.3 L 623 1359.34 L 613 1359.45 L 603 1360 L 603.47 1360 L 603.48 1350 L 603.63 1340 L 602.54 1330 L 602.89 1320 L 603 1310 L 603 1310 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 148px; height: 1px; padding-top: 1335px; margin-left: 605px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Déclaration CLAT nominatif pour enquête autour du cas<br /><div style="text-align: center"></div></div></div></div></foreignObject><text x="605" y="1339" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration CLAT nominati...</text></switch></g><rect x="668" y="1280" width="20" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 18px; height: 1px; padding-top: 1290px; margin-left: 669px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 19px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">+</div></div></div></foreignObject><text x="678" y="1296" fill="#000000" font-family="Pangolin" font-size="19px" text-anchor="middle">+</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>